![Luke Düster](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luke Düster
Directeur/Membre du Conseil chez
VALERITAS INC
Profil
Luke Düster is a member of CRG’s Founders Group, serves as Chief Investment Officer, ESG Champion and a Member of CRG’s Investment Committee and ESG Committee.
He is also responsible for portfolio management and portfolio company exits.
Mr. Düster also serves on the board of directors of several CRG portfolio companies, both as a director and as an observer, and serves portfolio company senior management teams as an advisor on financial, strategic and operational initiatives.
He has led investments in companies such as Neotract, Nevro, Omeros, BioDelivery Sciences, Strongbridge Biopharma, Silk Road Medical, NanoString Technologies and many others.
Prior to CRG, Mr. Düster was an investment banker at Harris Williams & Co., where he advised private equity and corporate clients across a broad range of M&A assignments.
Mr. Düster also held investment banking roles at the Wallach Company, a regional investment banking boutique, and at the Nord Companies, a healthcare advisory firm.
Mr. Düster received a bachelor’s degree from the University of Colorado at Boulder in 1997, where he graduated summa cum laude.
He received an M.B.A with honors from the Wharton School at the University of Pennsylvania in 2004.
Postes actifs de Luke Düster
| Sociétés | Poste | Début |
|---|---|---|
| VALERITAS INC | Directeur/Membre du Conseil | 01/01/2016 |
CR Group LP
 CR Group LP Investment ManagersFinance CRG invests in both public and private small & middle market companies located across the globe, primarily in the United States, Europe, Australia and Canada with revenues under USD 300 million. The firm targets companies operating in the fields of consumer health, life sciences, and healthcare services & IT. sectors. It provides financing in the form of debt and equity for growth transactions with an investment size ranging from USD 20 to 300 million. | Directeur en chef des Investissements | - |
Anciens postes connus de Luke Düster
| Sociétés | Poste | Fin |
|---|---|---|
| VALERITAS HOLDINGS, INC. | Directeur/Membre du Conseil | 21/12/2019 |
| ZYLA LIFE SCIENCES | Directeur/Membre du Conseil | 18/06/2019 |
Harris Williams & Co.
 Harris Williams & Co. Investment Banks/BrokersFinance Operates as an investment bank that provides M&A advisory services | Corporate Officer/Principal | 01/01/2009 |
Wallach Co.
 Wallach Co. Investment ManagersFinance Investment banking firm | Corporate Officer/Principal | 01/01/2002 |
Formation de Luke Düster
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for patients with acute and chronic pain | Health Technology |
Valeritas Holdings, Inc.
 Valeritas Holdings, Inc. Medical SpecialtiesHealth Technology Develops and commercializes insulin drug delivery devices | Health Technology |
Harris Williams & Co.
Harris Williams & Co. Investment Banks/BrokersFinance Operates as an investment bank that provides M&A advisory services | Finance |
Wallach Co.
Wallach Co. Investment ManagersFinance Investment banking firm | Finance |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes | Health Technology |
CR Group LP
CR Group LP Investment ManagersFinance CRG invests in both public and private small & middle market companies located across the globe, primarily in the United States, Europe, Australia and Canada with revenues under USD 300 million. The firm targets companies operating in the fields of consumer health, life sciences, and healthcare services & IT. sectors. It provides financing in the form of debt and equity for growth transactions with an investment size ranging from USD 20 to 300 million. | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colorado Boulder
 University of Colorado Boulder Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
